GTx Inc. to merge with Oncternal Therapeutics, end Memphis operations
Memphis-based biopharmaceutical company GTx Inc. and a San Diego-based biotech firm are planning a reverse merger that will end GTx’s Memphis operations.
Topics
GTx Inc. Oncternal TherapeuticsNatalie Pilgrim
Natalie Pilgrim is a Memphis native and a graduate of the University of Memphis. She is a digital producer for The Daily Memphian.
Kate Crawford
Associate editor Kate Crawford is a native Memphian and third-generation University of Memphis alumna.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.